Activation of AKT signaling promotes epithelial–mesenchymal transition and tumor growth in colorectal cancer cells

Activation of the serine–threonine protein kinase AKT has emerged as a central feature of epithelial–mesenchymal transition (EMT), which is the initial step for metastasis in many cancer models, including colorectal cancer. The focus of our study was to dissect the role of AKT and its molecular regulation of EMT in colorectal cancer. HCT‐116 colorectal cancer cells stably overexpressing AKT (AKT/HCT‐116) showed significantly higher cell proliferation compared with vector‐transfected cells (pCMV/HCT‐116). Elevated expression of important EMT‐related transcription factors and genes such as Snail, Slug, β‐catenin, vimentin, and MMP‐9 correlated with increased migration and invasion by AKT/HCT‐116 cells. Further, in vivo studies confirmed that AKT/HCT‐116 xenografts were highly aggressive and angiogenic in nature compared with pCMV/HCT‐116 xenografts. Molecular analysis of tumor samples revealed transcriptional regulation of Snail, Slug, β‐catenin, MMP‐2, and MMP‐9 in AKT/HCT‐116 tumors. These results were supported by immunohistochemistry analysis. Low levels of E‐cadherin expression with a concomitant increase in and nuclear localization of β‐catenin were evident in AKT/HCT‐116 tumors compared with control tumors. Increased microvessel formation coincident with high expression of Factor VIII and increased numbers of reticulocytes confirmed the angiogenic property of AKT/HCT‐116 tumors. Our results confirm the potential role of AKT signaling in regulating EMT and angiogenesis in colorectal cancer and suggest that inhibition of AKT can serve as an important therapeutic strategy in modulating EMT in colorectal cancer growth and metastasis. © 2013 Wiley Periodicals, Inc.

[1]  P. Tsichlis,et al.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. , 1999, Annual review of biochemistry.

[2]  F. Sipos,et al.  Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. , 2012, World journal of gastroenterology.

[3]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[4]  A. Martelli,et al.  The emerging multiple roles of nuclear Akt. , 2012, Biochimica et biophysica acta.

[5]  Jongkyeong Chung,et al.  Akt: versatile mediator of cell survival and beyond. , 2002, Journal of biochemistry and molecular biology.

[6]  R. Pearson,et al.  Targeting PI3 kinase/AKT/mTOR signaling in cancer. , 2012, Critical reviews in oncogenesis.

[7]  T. Kume,et al.  The Foxc2 transcription factor regulates tumor angiogenesis. , 2010, Biochemical and biophysical research communications.

[8]  G. Sethi,et al.  Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. , 2010, Biochimica et biophysica acta.

[9]  J. Cheng,et al.  AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Jiang,et al.  PI3K/PTEN signaling in angiogenesis and tumorigenesis. , 2009, Advances in cancer research.

[11]  J. Rubin,et al.  Rapid, Wnt-Induced Changes in GSK3β Associations that Regulate β-Catenin Stabilization Are Mediated by Gα Proteins , 2005, Current Biology.

[12]  R. Gaynor,et al.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. , 2003, Molecular biology of the cell.

[13]  Kristina M. Cook,et al.  Angiogenesis Inhibitors: Current Strategies and Future Prospects , 2010, CA: a cancer journal for clinicians.

[14]  M. Guarino Epithelial-mesenchymal transition and tumour invasion. , 2007, The international journal of biochemistry & cell biology.

[15]  M. Malafa,et al.  Targeting AKT protein kinase in gastric cancer. , 2011, Anticancer research.

[16]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[17]  Yingwei Chen,et al.  PI3K: A potential therapeutic target for cancer , 2012, Journal of cellular physiology.

[18]  V. Steele,et al.  Targeting the AKT protein kinase for cancer chemoprevention , 2007, Molecular Cancer Therapeutics.

[19]  L. Nelles,et al.  Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition , 2007, Oncogene.

[20]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[21]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[22]  G. Berx,et al.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. , 2006, Gastroenterology.

[23]  L. Milanesi,et al.  Systems biology of the metabolic network regulated by the Akt pathway. , 2012, Biotechnology advances.

[24]  P. Dennis,et al.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.

[25]  S. Sheng,et al.  Metastasis and AKT activation , 2008, Cell cycle.

[26]  M. Tatari,et al.  EMT as the ultimate survival mechanism of cancer cells. , 2012, Seminars in cancer biology.

[27]  Y. Rojanasakul,et al.  Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  O. De Wever,et al.  Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[29]  K. Green Faculty Opinions recommendation of Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. , 2004 .

[30]  F. Arvelo,et al.  Biology of colorectal cancer , 2015, Ecancermedicalscience.

[31]  Avri Ben-Ze'ev,et al.  Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.

[32]  G. Christofori New signals from the invasive front , 2006, Nature.

[33]  T. Das,et al.  Induction of reactive oxygen species generation inhibits epithelial–mesenchymal transition and promotes growth arrest in prostate cancer cells , 2014, Molecular carcinogenesis.

[34]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[35]  J. Rubin,et al.  Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. , 2005, Current biology : CB.

[36]  Domenico Coppola,et al.  Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer , 2000, Oncogene.

[37]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[38]  J. Gordon,et al.  Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. , 1996, Genes & development.

[39]  S. Sanyal,et al.  Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[40]  E. Avizienyte,et al.  The Src-Induced Mesenchymal State in Late-Stage Colon Cancer Cells , 2005, Cells Tissues Organs.

[41]  H. Weiss,et al.  mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. , 2011, Cancer research.

[42]  G. Casey,et al.  The AKT/IκB kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κB and β-catenin , 2005, Oncogene.

[43]  G. Casey,et al.  The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. , 2005, Oncogene.

[44]  E. Woltering,et al.  Do primary neuroendocrine tumors and metastasis have the same characteristics? , 2012, The Journal of surgical research.

[45]  M. Sakamoto,et al.  Establishment of an ovarian metastasis model and possible involvement of E‐cadherin down‐regulation in the metastasis , 2008, Cancer science.

[46]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[47]  S. Shirasawa,et al.  Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA. , 2012, Carcinogenesis.

[48]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[49]  R. Ballotti,et al.  The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion , 2012, PloS one.

[50]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[51]  Sara M. Johnson,et al.  Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. , 2010, Journal of the American College of Surgeons.

[52]  L. Mauro,et al.  Prognostic value of E‐cadherin, beta‐catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma , 2006, Journal of surgical oncology.

[53]  C. Damodaran,et al.  Notch-1 Inhibition by Withaferin-A: A Therapeutic Target against Colon Carcinogenesis , 2010, Molecular Cancer Therapeutics.

[54]  Alfonso Bellacosa,et al.  AKT plays a central role in tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Alfonso Bellacosa,et al.  Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.